Publication | Closed Access

Specific active immunotherapy with a VEGF vaccine in patients with advanced solid tumors. Results of the CENTAURO antigen dose escalation phase I clinical trial

Vegf VaccineSpecific Active ImmunotherapyTumor ImmunologyCancer TherapeuticsVaccine ResearchMedicineImmunologyVaccine TrialAdvanced Solid TumorsTherapeutic VaccineImmunotherapyOncologyRadiation OncologyHealth Sciences